B. Riley Financial suspends dividends on preferred shares, plans to pay off notes
B. Riley Financial Inc (NASDAQ:RILY). has paused the payment of dividends on two of its preferred stock offerings. The ...
B.Riley Financial Reaffirms Their Buy Rating on Altimmune (ALT)
B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Altimmune (ALT – Research Report) yesterday and set a price target of ...
B. Riley upgrades Redwire on growth potential from Edge Autonomy acquisition
Learn about the latest financial trends and strategies in our comprehensive article written by a financial expert.
ClearPoint Neuro price target raised to $20 from $15 at B. Riley
B. Riley analyst Kyle Bauser raised the firm’s price target on ClearPoint Neuro (CLPT) to $20 from $15 and keeps a Buy rating ...
B.Riley Financial Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)
In a report released yesterday, Mayank Mamtani from B.Riley Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), ...
FY2024 EPS Estimates for Ladder Capital Cut by B. Riley
Analysts at B. Riley reduced their FY2024 earnings estimates for shares of Ladder Capital in a research report issued to clients and investors on Monday, January 27th. B. Riley analyst R. Binner now ...
B. Riley Suspends Preferred Payouts Ahead of Note Redemption
B. Riley Financial Inc. suspended dividends on a pair of its preferred shares, holding off on cash payments to some investors ...
Morningstar2d
B. Riley Financial Inc
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
What is B. Riley’s Forecast for CUBI Q1 Earnings?
B. Riley issued their Q1 2025 earnings estimates for Customers Bancorp in a research note issued to investors on Monday, ...